Literature DB >> 12169751

Fatal re-expansion pulmonary edema associated with increased lung IL-8 levels following high-dose chemotherapy and autologous stem cell transplant.

Stavros Garantziotis1, Karan S Bhalla, Gwynn D Long, James J Vredenburgh, Rodney J Folz.   

Abstract

Re-expansion pulmonary edema (REPE) leading to hypoxic respiratory failure and death occurred following a unilateral low-volume (750 ml) thoracentesis in a young patient 8 days after high-dose chemotherapy and autologous stem cell transplantation (HDC/ASCT) for advanced-stage breast cancer. A higher volume (1,000 ml) thoracentesis from the contralateral lung, 2 weeks prior to HDC/ASCT, showed no clinical consequences. We have recently demonstrated increased levels of inflammatory cytokines in the lungs of patients following HDC/ASCT, a finding which may predispose them to exaggerated inflammatory lung injury. In postmortem analysis, this patient's lung demonstrated substantial intra-alveolar edema and marked elevation in interleukin-8, detected by immunohistochemistry. This suggests that patients who have recently undergone HDC/ASCT may be at increased risk for the development of REPE following thoracentesis. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12169751     DOI: 10.1159/000063260

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  2 in total

1.  Acute Hypoxemic Respiratory Failure after Large-Volume Thoracentesis. Mechanisms of Pleural Fluid Formation and Reexpansion Pulmonary Edema.

Authors:  James M Walter; Michael A Matthay; Colin T Gillespie; Thomas Corbridge
Journal:  Ann Am Thorac Soc       Date:  2016-03

2.  Increased interleukin-8 in epithelial lining fluid of collapsed lungs during one-lung ventilation for thoracotomy.

Authors:  Yoshimichi Komatsu; Hiroshi Yamamoto; Kenji Tsushima; Shino Furuya; Sumiko Yoshikawa; Masanori Yasuo; Keishi Kubo; Yoshitaka Yamazaki; Joh Hasegawa; Takashi Eguchi; Ryuichi Kondo; Kazuo Yoshida; Tomonobu Koizumi
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.